Filed: 2026-04-10 AccNo: 0001213900-26-042200 Size: 307 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.01: Completion of Acquisition or Disposition of Assets Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
NS
Article DetailSEC EDGAR Filings
SEC EDGAR Filings
8-K - BiomX Inc. - 1.01 / 2.01 / 3.02 / 7.01 / 9.01
Filed:
2026-04-13
AccNo:
0001213900-26-042811
Size:
593 KB
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits
发布时间04/13 13:23 UTC
首次发现04/13 13:23 UTC
热度108.0
重要度90
情绪+0.06
站内整理正文
优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 1109 字符
Form 8-K - Current report: SEC Accession No. 0001213900-26-042811
Filing Date: 2026-04-13
Accepted: 2026-04-13 09:23:01
Documents: 16
Period of Report: 2026-04-13
Items: Item 1.01: Entry into a Material Definitive Agreement Item 2.01: Completion of Acquisition or Disposition of Assets Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
BiomX Inc. (Filer) CIK : 0001739174 (see all company filings) EIN. : 823364020 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-38762 | Film No.: 26856622 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)
1 | CURRENT REPORT | ea0285293-8k_biomx.htm iXBRL | 8-K
2 | UNSECURED CONVERTIBLE PROMISSORY NOTE, DATED APRIL 6, 2026, ISSUED BY BIOMX INC. | ea028529301ex4-1.htm | EX-4.1
3 | PRE-FUNDED WARRANT, DATED APRIL 6, 2026, ISSUED BY BIOMX INC. TO MANDRAGOLA LTD | ea028529301ex4-2.htm | EX-4.2
4 | FIVE YEAR WARRANT, DATED APRIL 6, 2026, ISSUED BY BIOMX INC. TO MANDRAGOLA LTD | ea028529301ex4-3.htm | EX-4.3
同簇相关文章
从当前文章回到同一事件簇里的其他来源或补充材料。
1 篇